Related Experiment Video
Updated: May 21, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury
Kimiko Kobayashi1, Hiroki Yamanaka, Fujio Yanamoto
1Department of Anatomy and Neuroscience, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
Abstract:
A prominent signaling pathway in the development of neuropathic pain involves ATP acting on microglial purinergic receptors. Among the P2Y metabotropic receptors, we reported before that the P2Y12 receptor is upregulated in microglia following nerve injury and involved in the phosphorylation of p38 MAPK, and in the development of pain behavior. In this study, we examined the expression of P2Y6, P2Y13, and P2Y14 receptors in the spinal cord and whether these receptors are involved in the pathogenesis of neuropathic pain following peripheral nerve injury. We found that spared nerve injury induced a dramatic increase of not only P2Y12, but also P2Y6, 13, and 14 receptor mRNA expression in spinal microglia. The increase continued for at least 2 weeks after injury. To determine whether p38 MAPK can induce the expression of P2Y receptors, we administered intrathecally the p38 MAPK inhibitor SB203580 and found that it significantly suppressed P2Y6, P2Y13, and P2Y14 but not P2Y12 mRNAs. Intrathecal injection of the specific P2Y6 antagonist MRS2578, specific P2Y13 antagonist MRS2211 or P2Y14 antisense LNA, attenuated mechanical pain hypersensitivity. The mixture of three antagonists for P2Y6, 12, and 13 showed a longer suppressive effect on pain behavior than the individual treatments. Our data demonstrate that ATP and other nucleotides may stimulate activated microglia with the upregulation of P2Y6, P2Y12, P2Y13, and P2Y14 receptors following nerve injury and these receptors are involved in the development of neuropathic pain.
Insights
Neuropathic pain involves microglial purinergic receptors. This study shows P2Y6, P2Y12, P2Y13, and P2Y14 receptors are upregulated after nerve injury and contribute to pain development.
Area of Science:
- Neuroscience
- Pain Research
- Molecular Biology
Background:
- Neuropathic pain pathogenesis involves microglial purinergic signaling.
- P2Y12 receptors are known to be upregulated post-nerve injury, influencing pain behavior.
- The role of other P2Y receptors in neuropathic pain remains less understood.
Purpose of the Study:
- To investigate the expression of P2Y6, P2Y13, and P2Y14 receptors in the spinal cord following peripheral nerve injury.
- To determine the involvement of these P2Y receptors in the development of neuropathic pain.
- To explore the relationship between p38 MAPK signaling and P2Y receptor expression.
Main Methods:
- Spared nerve injury model in rodents.
- Quantitative real-time PCR to assess mRNA expression of P2Y receptors in spinal microglia.
- Intrathecal administration of p38 MAPK inhibitor (SB203580).
- Intrathecal administration of specific antagonists/antisense for P2Y6, P2Y13, and P2Y14 receptors.
- Assessment of mechanical pain hypersensitivity.
Main Results:
- Spared nerve injury significantly increased mRNA expression of P2Y6, P2Y12, P2Y13, and P2Y14 receptors in spinal microglia for at least two weeks.
- p38 MAPK inhibition suppressed P2Y6, P2Y13, and P2Y14 mRNA expression but not P2Y12.
- Pharmacological blockade of P2Y6, P2Y13, or P2Y14 receptors attenuated mechanical pain hypersensitivity.
- A combination of antagonists for P2Y6, P2Y12, and P2Y13 receptors demonstrated a more prolonged suppression of pain behavior.
Conclusions:
- ATP and other nucleotides activate microglia, leading to the upregulation of P2Y6, P2Y12, P2Y13, and P2Y14 receptors after nerve injury.
- These upregulated P2Y receptors play a crucial role in the pathogenesis of neuropathic pain.
- Targeting these purinergic receptors represents a potential therapeutic strategy for neuropathic pain management.
Related Concept Videos
Nociception
Neurogenesis and Regeneration of Nervous Tissue
Local Anesthetics: Differential Sensitivity of Nerve Fibers
